1350 related articles for article (PubMed ID: 22465546)
21. Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer.
Guney Eskiler G; Cecener G; Dikmen G; Egeli U; Tunca B
Eur J Pharm Sci; 2018 Jul; 120():73-88. PubMed ID: 29719240
[TBL] [Abstract][Full Text] [Related]
22. Solid lipid nanoparticles for ocular drug delivery.
Seyfoddin A; Shaw J; Al-Kassas R
Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
[TBL] [Abstract][Full Text] [Related]
23. Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.
Cheema SK; Gobin AS; Rhea R; Lopez-Berestein G; Newman RA; Mathur AB
Int J Pharm; 2007 Aug; 341(1-2):221-9. PubMed ID: 17499461
[TBL] [Abstract][Full Text] [Related]
24. Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.
Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
Ther Deliv; 2010 Jul; 1(1):63-73. PubMed ID: 22816120
[TBL] [Abstract][Full Text] [Related]
25. Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro.
Wan F; You J; Sun Y; Zhang XG; Cui FD; Du YZ; Yuan H; Hu FQ
Int J Pharm; 2008 Jul; 359(1-2):104-10. PubMed ID: 18450394
[TBL] [Abstract][Full Text] [Related]
26. The augmented anticancer potential of AP9-cd loaded solid lipid nanoparticles in human leukemia Molt-4 cells and experimental tumor.
Bhushan S; Kakkar V; Pal HC; Mondhe DM; Kaur IP
Chem Biol Interact; 2016 Jan; 244():84-93. PubMed ID: 26620693
[TBL] [Abstract][Full Text] [Related]
27. Solid lipid nanoparticles as drug delivery systems.
Manjunath K; Reddy JS; Venkateswarlu V
Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465
[TBL] [Abstract][Full Text] [Related]
28. Improvement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticles.
Hu L; Jia H; Luo Z; Liu C; Xing Q
Pharmazie; 2010 Feb; 65(2):110-3. PubMed ID: 20225654
[TBL] [Abstract][Full Text] [Related]
29. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
Pandey V; Gajbhiye KR; Soni V
Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
[TBL] [Abstract][Full Text] [Related]
30. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.
Chalikwar SS; Belgamwar VS; Talele VR; Surana SJ; Patil MU
Colloids Surf B Biointerfaces; 2012 Sep; 97():109-16. PubMed ID: 22609590
[TBL] [Abstract][Full Text] [Related]
31. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration.
Shah MK; Madan P; Lin S
Pharm Dev Technol; 2014 Jun; 19(4):475-85. PubMed ID: 23697916
[TBL] [Abstract][Full Text] [Related]
32. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
[TBL] [Abstract][Full Text] [Related]
33. Development of plumbagin-loaded phospholipid-Tween® 80 mixed micelles: formulation, optimization, effect on breast cancer cells and human blood/serum compatibility testing.
Bothiraja C; Kapare HS; Pawar AP; Shaikh KS
Ther Deliv; 2013 Oct; 4(10):1247-59. PubMed ID: 24116910
[TBL] [Abstract][Full Text] [Related]
34. Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles.
Zhu RR; Qin LL; Wang M; Wu SM; Wang SL; Zhang R; Liu ZX; Sun XY; Yao SD
Nanotechnology; 2009 Feb; 20(5):055702. PubMed ID: 19417361
[TBL] [Abstract][Full Text] [Related]
35. Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats.
Zhang WL; Liu JP; Liu XX; Chen ZQ
Yao Xue Xue Bao; 2009 Dec; 44(12):1421-8. PubMed ID: 21348419
[TBL] [Abstract][Full Text] [Related]
36. Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization.
Maurya L; Singh S; Rajamanickam VM; Narayan G
Curr Drug Deliv; 2018; 15(8):1135-1145. PubMed ID: 29629662
[TBL] [Abstract][Full Text] [Related]
37. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
[TBL] [Abstract][Full Text] [Related]
38. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
[TBL] [Abstract][Full Text] [Related]
39. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
Ostacolo L; Marra M; Ungaro F; Zappavigna S; Maglio G; Quaglia F; Abbruzzese A; Caraglia M
J Control Release; 2010 Dec; 148(2):255-63. PubMed ID: 20816710
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles.
Varshosaz J; Minayian M; Moazen E
J Liposome Res; 2010 Jun; 20(2):115-23. PubMed ID: 19694503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
